Evidence map›Paper›PMID 28760776›Full record

ArticleMolecular and cellular biology2017

TIE2 Associates with Caveolae and Regulates Caveolin-1 To Promote Their Nuclear Translocation.

Mohammad B Hossain, Rehnuma Shifat, Jingyi Li, Xuemei Luo, Kenneth R Hess, Yisel Rivera-Molina, Francisco Puerta Martinez, Hong Jiang, Frederick F Lang, Mien-Chie Hung and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 3 countries.

Mohammad B HossainDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA mbhossain@mdanderson.org cmanzano@mdanderson.org.ORCID http://orcid.org/0000-0003-0384-544X
Rehnuma ShifatDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jingyi LiDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Xuemei LuoBiomolecular Resource Facility, The University of Texas Medical Branch, Galveston, Texas, USA.
Kenneth R HessDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yisel Rivera-MolinaDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Francisco Puerta MartinezDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hong JiangDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Frederick F LangDepartment of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Mien-Chie HungDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Juan FueyoDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Candelaria Gomez-ManzanoDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA mbhossain@mdanderson.org cmanzano@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USThe University of Texas Medical Branch at Galveston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain TumorsP50CA127001 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Juan Fueyo · 2008 to 2026
$41.2M
Role of TEMs in brain tumor dispersalR01NS069964 · NINDS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GOMEZ-MANZANO, CANDELARIA, MARINI, FRANK C. · 2010 to 2014
$1.7M
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA127001NINDS NIH HHS R01 NS069964
6 · The paper itself

Abstract

DNA repair pathways are aberrant in cancer, enabling tumor cells to survive standard therapies-chemotherapy and radiotherapy. Our group previously reported that, upon irradiation, the membrane-bound tyrosine kinase receptor TIE2 translocates into the nucleus and phosphorylates histone H4 at Tyr51, recruiting ABL1 to the DNA repair complexes that participate in the nonhomologous end-joining pathway. However, no specific molecular mechanisms of TIE2 endocytosis have been reported. Here, we show that irradiation or ligand-induced TIE2 trafficking is dependent on caveolin-1, the main component of caveolae. Subcellular fractionation and confocal microscopy demonstrated TIE2/caveolin-1 complexes in the nucleus, and using inhibitor or small interfering RNAs (siRNAs) against caveolin-1 or Tie2 inhibited their trafficking. TIE2 was found in caveolae and directly phosphorylated caveolin-1 at Tyr14

Indexed as

AnimalsCaveolaeCaveolin 1Cell Line, TumorCell NucleusGene Expression Regulation, NeoplasticGliomaHEK293 CellsHeLa CellsHumansHuman Umbilical Vein Endothelial CellsPhosphorylationProtein TransportReceptor, TIE-2Up-RegulationCAV1 protein, humanCaveolin 1Receptor, TIE-2brain tumorcaveolin-1nuclear translocationnuclear transportradioresistanceradiosensitivityTIE2

Identifiers

PMID28760776
PMCPMC5640814
OpenAlexW2742011399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.